Skip to content
HowShorted

ThermoGenesis Holdings, Inc. short interest in 2021

In 2021, ThermoGenesis Holdings, Inc.'s disclosed short interest ran from 13.00% of shares outstanding on 15 Jan 2021 to 2.48% on 31 Dec 2021, a change of -10.52 percentage points. The year's high was 20.85% on 12 Feb 2021 and its low 1.81% on 15 Dec 2021, averaging 7.12% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.96 days on 15 Sep 2021. Full history: ThermoGenesis Holdings, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024

Aggregate net short position time series for ThermoGenesis Holdings, Inc. in 2021

2021 in figures

Start of year
13.00% (15 Jan 2021)
End of year
2.48% (31 Dec 2021)
Change
-10.52 pp
High
20.85% (12 Feb 2021)
Low
1.81% (15 Dec 2021)
Average
7.12%
Highest days to cover
7.96 (15 Sep 2021)
SEC filings marked
8

Every report in 2021

ThermoGenesis Holdings, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 202113.00%1.00
29 Jan 202117.55%1.00
12 Feb 202120.85%1.00
26 Feb 202117.91%1.82
15 Mar 202112.41%1.59
31 Mar 202112.23%2.5410-K filed, results (8-K)
15 Apr 202110.68%4.24
30 Apr 20217.70%4.20
14 May 20218.23%2.8310-Q filed, results (8-K)
28 May 20217.33%2.21
15 Jun 20214.65%3.45
30 Jun 20213.44%3.19
15 Jul 20212.68%1.00
30 Jul 20214.42%1.42
13 Aug 20214.91%1.9710-Q filed, results (8-K)
31 Aug 20213.56%4.42
15 Sep 20212.60%7.96
30 Sep 20211.98%3.63
15 Oct 20212.29%1.85
29 Oct 20211.98%1.00
15 Nov 20212.34%1.9010-Q filed, results (8-K)
30 Nov 20213.85%1.00
15 Dec 20211.81%1.73
31 Dec 20212.48%1.00

See also: ThermoGenesis Holdings, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.